ChemCatChem · 2022 · 21 citations · 42 references
Natural SciencesChemistryMedicinal ChemistryDrug DiscoveryProtein EngineeringSynthetic Medicinal ChemistryCross-coupling ReactionsLinker ChemistryPhotochemical SynthesisPhotochemistryContinuous-flow Photochemical SynthesisFlow PhotochemistryLenalidomide TherapyMedicinal Chemistry ApplicationsPhotoredox Cross-couplingPhotoredox FunctionalizationReductive Cross-couplingTargeted Protein Degradation
Abstract Proteolysis‐targeting chimeras (PROTACs) have recently emerged as powerful molecules for targeted protein degradation. As such, synthetic methods for their modular synthesis are of prime importance in medicinal chemistry. We report the development of both batch and flow photoredox methodologies for C sp 3 −C sp 2 cross‐electrophile couplings of alkyl bromides with E3 ligase‐binding aryl bromides (thalidomide and lenalidomide derivatives). Despite the challenging reaction system, containing several insoluble species, conditions were discovered to facilitate stable processing in an oscillatory flow photochemical reactor. The flow approach can enable processing of larger material quantities in a shorter time period. A range of saturated linker molecules, with various functional handles, were successfully combined with four ligand variants using the developed conditions. Finally, scalability in batch and use of an organic photocatalyst were explored.
42
Photoredox Catalysis in Organic Chemistry
Megan H. Shaw, Jack Twilton, David W. C. MacMillan · The Journal of Organic Chemistry · 2016 · 3.1K citations · Full text
Kathleen M. Sakamoto, Kyung B. Kim, Akiko Kumagai et al. · Proceedings of the National Academy of Sciences · 2001 · 2.5K citations · Full text
Identification of a Primary Target of Thalidomide Teratogenicity
Takumi Ito, Hideki Ando, Takayuki Suzuki et al. · Science · 2010 · 2.1K citations
Escape from Flatland 2: complexity and promiscuity
Frank Lovering · MedChemComm · 2012 · 1.4K citations